FOLLOWING UP A METAL SEQUESTERING THERAPY BY GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROMETRY

ROMER A. ROMERO; JANETH A. NAVARRO; VICTOR A. GRANADILLO

doi:10.2116/analsci.7.Supple_837

ROMER A. ROMERO, JANETH A. NAVARRO, VICTOR A. GRANADILLO

Author information

Keywords: desferrioxamine B, graphite furnace atomic absorption spectrometry, peritoneal dialysis, whole blood metals

JOURNAL FREE ACCESS

1991 Volume 7 Issue Supple Pages 837-840

DOI https://doi.org/10.2116/analsci.7.Supple_837

Details

Abstract

Removal of aluminum, copper, zinc, iron and lead was monitored by using graphite furnace atomic absorption spectrometry (GFAAS), in five renal patients undergoing peritoneal dialysis and receiving a chelation therapy with desferrioxamine B. Aluminum losses were between 0.3 and 6.7mg; mean removal of 42±5μg Pb was obtained. Copper, zinc and iron were not significantly affected. GFAAS proved to be useful to follow up metal changes in humans.

Corresponding author

Register with J-STAGE for free!